Trial of Controversial Alzheimer’s Drug Halted After Disappointing Results November 25, 2024 900 people with mild to moderate Alzheimer’s disease. Cassava Sciences said that its drug did not significantly reduce cognitive decline in 1 NYT NYT > Business NYTimes +